Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹18.90
Market cap: ₹44.81 Cr
Revenue (annual): ₹92.74 Cr
Net profit (annual): ₹4.96 Cr
P/E (TTM): 5.9×Sector 47.3×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 4 Board Meeting Date 4 Annual General Meeting 4 Board Meeting Outcome 3 Management Change 2 Capacity Expansion 2 Results Update 1 Legal & Regulatory 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

10 Apr 2026 14:39 IST BSE

Capital Structure Change

Kabra Drugs Capital Structure Change

Kabra Drugs Limited's board will meet on April 21, 2026, to approve diversifying into sectors including defense equipment, AI, and dairy. The board will also consider appointing Ms. Monam Kapoor as an Independent Director and initiate a postal ballot process for these proposals.

Read the filing ↗